Beijing Jingsource Pharmaceutical Technology Co., Ltd. — Verified Supplier
About Beijing Jingsource Pharmaceutical Technology Co., Ltd. - Pharmaceutical Intermediate Supplier in China
Beijing Jingsource Pharmaceutical Technology Co., Ltd. is located in China, with 5 active products in its catalogue. The company lists various pharmaceutical intermediates, including Entecavir intermediate 7, Entecavir intermediate 8, Entecavir monohydrate, Entecavir intermediate 4, and Entecavir intermediate 8 isomer. These products are likely classified under the HS code families for pharmaceutical intermediates, which typically range from 2901 to 2942. Buyers of these products usually require specifications, such as purity and moisture content, to ensure the quality of the intermediates.
The pharmaceutical industry in China is a significant sector, with many companies like Beijing Jingsource Pharmaceutical Technology Co., Ltd. contributing to the global supply of pharmaceutical intermediates. The country's pharmaceutical exports are subject to regulations, such as those related to the registration and licensing of pharmaceutical manufacturers. As a result, buyers should verify the supplier's compliance with these regulations and request relevant documents, such as a Good Manufacturing Practice (GMP) certificate.
Product Range and Specialties of Beijing Jingsource Pharmaceutical Technology Co., Ltd.
Beijing Jingsource Pharmaceutical Technology Co., Ltd.'s product range includes various pharmaceutical intermediates, which are typically used in the production of active pharmaceutical ingredients (APIs). The company's catalogue includes Entecavir intermediates, which are used in the synthesis of Entecavir, an antiviral medication. Buyers of these products should request specifications, such as the intermediate's purity, moisture content, and impurity profile, to ensure the quality of the product. Additionally, buyers may want to request information on the supplier's quality control processes, such as testing and inspection procedures, to ensure that the products meet their requirements.
Trade and Export Information - Beijing Jingsource Pharmaceutical Technology Co., Ltd.
Exporters of pharmaceutical intermediates from China, like Beijing Jingsource Pharmaceutical Technology Co., Ltd., typically ship their products to regions with significant pharmaceutical manufacturing industries, such as North America, Europe, and India. The HS code families for pharmaceutical intermediates, which range from 2901 to 2942, are used to classify these products for customs and regulatory purposes. Buyers should be aware of the relevant regulations and certifications required for the importation of these products, such as compliance with GMP and registration with the relevant regulatory authorities. The Incoterms for these shipments are usually CIF or FOB, depending on the agreement between the buyer and the supplier.
Sourcing from Beijing Jingsource Pharmaceutical Technology Co., Ltd. - Buyer Guidance
When sourcing from Beijing Jingsource Pharmaceutical Technology Co., Ltd., buyers should request specifications, such as purity and moisture content, to ensure the quality of the pharmaceutical intermediates. Additionally, buyers should verify the supplier's compliance with relevant regulations, such as GMP, and request relevant documents, such as a GMP certificate. It is also recommended that buyers request information on the supplier's quality control processes, such as testing and inspection procedures, to ensure that the products meet their requirements. Furthermore, buyers should confirm the packaging and shipping arrangements, including the use of suitable containers and transportation methods, to prevent damage or contamination of the products.
Frequently Asked Questions About Beijing Jingsource Pharmaceutical Technology Co., Ltd.
What products does Beijing Jingsource Pharmaceutical Technology Co., Ltd. offer?
Beijing Jingsource Pharmaceutical Technology Co., Ltd. offers various pharmaceutical intermediates, including Entecavir intermediate 7, Entecavir intermediate 8, Entecavir monohydrate, Entecavir intermediate 4, and Entecavir intermediate 8 isomer.
What specifications should I request for the pharmaceutical intermediates?
Buyers should request specifications, such as purity, moisture content, and impurity profile, to ensure the quality of the pharmaceutical intermediates.
What regulations should I be aware of when importing pharmaceutical intermediates from China?
Buyers should be aware of the relevant regulations, such as compliance with GMP and registration with the relevant regulatory authorities, when importing pharmaceutical intermediates from China.
What is the typical packaging for pharmaceutical intermediates?
The typical packaging for pharmaceutical intermediates includes suitable containers, such as drums or bags, and transportation methods, such as sea or air freight, to prevent damage or contamination of the products.
What is the MOQ for the pharmaceutical intermediates?
The MOQ for the pharmaceutical intermediates may vary depending on the supplier and the specific product, but buyers should confirm this information with the supplier before placing an order.
How can I verify the quality of the pharmaceutical intermediates?
Buyers can verify the quality of the pharmaceutical intermediates by requesting test reports, inspection certificates, and other relevant documents from the supplier.
What is the lead time for the pharmaceutical intermediates?
The lead time for the pharmaceutical intermediates may vary depending on the supplier and the specific product, but buyers should confirm this information with the supplier before placing an order.
Can I request a sample of the pharmaceutical intermediates?
Yes, buyers can request a sample of the pharmaceutical intermediates to verify the quality and specifications of the product before placing a larger order.



